033 eV The experimental IVT data are also analyzed statistically using the extracted
values of Phi to build Lip a Gaussian distribution of barrier heights. Including the standard deviation and a mean SBH of 1.126 eV, Which Should be analogous to file SBH extracted from capacitance-voltage (C-V) measurements. Both techniques yield accurate values of A** for SiC. However, the C-V analysis did not correlate with the mean SBH as expected. (C) 2009 American Institute of Physics. [doi: 10.1063/1.3255976]“
“Background: Patients with advanced heart failure (HF) have high rates of pain and other symptoms that diminish quality of life. We know little about the characteristics and correlates of pain in patients with advanced HF.
Methods and Results: We identified pain prevalence, location, character, severity, frequency, and correlates in 347 outpatients with advanced HF enrolled from hospices and clinics. We evaluated GSK1210151A the correlation of pain with HF-related quality of life, mortality, symptoms and health problems, and current treatments for pain. Pain at any site was reported by 293 patients (84.4%), and 138 (39.5%) reported pain at more than one site. The most common site of pain was the legs below the knees (32.3% of subjects). Pain interfered with activity for 70% of patients. BVD-523 order Pain was “”severe”" or “”very severe”" for 28.6% of subjects with chest pain, and for 38.9% of those with
other sites of pain. The only medication reported to provide pain relief was opioids, prescribed for 34.1% of subjects (P = .001). The strongest predictors of pain were degenerative joint disease (DJD) (odds ratio [OR] 14.95, 95% confidence interval [CI] 3.9-56.0; P < .001), other arthritis (OR 2.8, 95% CI 1.20-6.62; P = .017), shortness of breath (OR 3.27, 95% CI 1.47-7.28; P = .004), and angina pectoris (OR
3.38, 95% CI 1.30-8.81; P = .013).
Conclusions: Pain occurred at multiple sites in patients with advanced HF. Pain correlated with DJD or other arthritis, shortness of breath, and angina. Only opioid analgesics provided relief Bromosporine of pain. Future research should evaluate the etiology of and interventions to manage pain in patients with HF. (J Cardiac Fail 2012;18:776-783)”
“An amorphous poly(ethylene terephthalate) (aPET) and a semicrystalline poly (ethylene terephthalate) obtained through the annealing Of aPET at 110 degrees C for 40 min (aPET-110-40) were treated in carbon dioxide (CO(2)) at 1500 psi and 35 degrees C for 1 h followed by treatment in a vacuum for various times to make samples containing various amounts of CO(2) residues in these two CO(2)-treated samples. Glass transition and cold crystallization as a function Of the amount of CO(2) residues in these two CO(2)-treated samples were investigated by temperature-modulated differential scanning calorimetry (TMDSC) and dynamic mechanical analysis (DMA).